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Infectious SIV resides in adipose tissue 
and induces metabolic defects in chronically 
infected rhesus macaques
Jacob Couturier1,2, Neeti Agarwal3, Pramod N. Nehete4, Wallace B. Baze4, Michael A. Barry5, 
K. Jagannadha Sastry2,4,6, Ashok Balasubramanyam3,7 and Dorothy E. Lewis1,2*
Abstract 
Background: HIV reservoirs pose major challenges to viral eradication. The main cellular reservoirs include CD4 T 
cells and macrophages, whereas anatomic reservoirs are thought to be primarily lymphoid tissues. Adipose tissue 
represents a potentially important non-lymphoid location for HIV replication and persistence because the stromal-
vascular-fraction (AT-SVF) contains activated innate and adaptive immune cells that increase in number during infec-
tions, obesity, and chronic inflammation.
Results: Adipose tissue from two groups of SHIV-SF162p3-infected (~4 weeks acute infection) or SIVmac251-infected 
(~38 weeks chronic infection) rhesus macaques (N = 8 for each group) were studied for immune cell content, viral 
infectiousness, and metabolic health. The AT-SVF cells from SHIV-infected monkeys contained abundant memory CD4 
and CD8 T cells, with fewer NKT cells and macrophages, and no B cells. Proviral DNA (Gag and Env) was readily detect-
able by nested PCR in AT-SVF cells from multiple adipose depots (subcutaneous and visceral) of acutely infected 
monkeys, but mostly from visceral fat. More importantly, viral outgrowth assays using input CD4 T cells derived from 
AT-SVF cells or peripheral blood of chronically infected monkeys resulted in robust replication of infectious virus from 
both AT-SVF and peripheral blood CD4 T cells. Chronically infected monkeys also experienced adipocyte dysfunction 
(suppression of major adipogenic genes) and systemic dyslipidemia (decreased serum total cholesterol and free fatty 
acids, and increased triglycerides), similar to metabolic abnormalities of HIV patients.
Conclusions: Adipose tissues of SIV-infected rhesus macaques become major compartments for infected immune 
cells, which in turn induce defects in adipose tissue metabolism.
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Background
Eradication and immune control of HIV is difficult due 
to the establishment of reservoirs and anatomic sanc-
tuaries [1, 2]. Memory CD4 T cells and macrophages 
are the primary hosts and cellular reservoirs for HIV 
in humans and SIV in non-human primates. Anatomic 
reservoirs for infected immune cells include lymphoid 
(lymph nodes, spleen, thymus, bone marrow, and GALT) 
and non-lymphoid (lungs, skin, liver, kidneys, reproduc-
tive, and nervous system) tissues. Antiretroviral therapy 
(ART) reduces the systemic viral load below the detec-
tion limits of clinical assays in most patients, but viral 
replication typically resumes if ART is interrupted [3]. 
ART is also incompletely effective in certain locations, 
such as CNS tissue and lymph nodes, due to unique cel-
lular barriers to ART drugs [4, 5]. Hence, understanding 
cellular and anatomic reservoirs for HIV, and how they 
may prevent adequate tissue penetration by ART drugs, 
is critical to achieving a cure.
A major organ that has been overlooked hitherto 
for a role in HIV pathogenesis is adipose tissue. It is 
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well-known that a range of immune cells reside in or 
migrate into adipose tissues and affect their metabolic 
signals [6, 7], but adipocytes and other adipose tissue-
resident cells interact with CD4 T cells and macrophages 
which has important implications for HIV pathogenesis. 
Anatomically, adipose tissue predominantly underlies the 
skin (subcutaneous fat) and surrounds abdominal organs 
(visceral fat). However, adipocytes are also intimately 
associated with most lymphoid tissues—lymph nodes 
are tightly encapsulated by adipose tissue, adipocytes are 
abundant within bone marrow, and the thymus gradually 
becomes filled with adipocytes during adult aging. Such 
an intricate arrangement is important during infections 
or immunological reactions because adipocytes are major 
sources of energy and survival signals for immune cells 
[8]. At the cellular level, adipose tissue is heterogeneous 
and composed of mature adipocytes (the predominant 
fraction containing lipid droplets and triglycerides), and 
the stromal-vascular-fraction (AT-SVF) which includes 
mainly preadipocytes (adipocyte precursors) and fibro-
blasts, mesenchymal stem cells (MSC), endothelial cells, 
and immune cells. Extensive studies in humans and mice 
have demonstrated the presence of virtually every type of 
innate and adaptive leukocyte within adipose tissue dur-
ing normal conditions, the composition and functions 
of which change dramatically in response to disease and 
inflammation. Importantly for HIV infection, the adipose 
tissue-resident CD4 T cells, which are predominantly 
activated memory CD4 T cells (CD45RO+CD69+HLA.
DR+CD25+) [9–13], phenotypically resemble those in 
other tissues where HIV persists. We recently demon-
strated for the first time the presence of memory CD4 T 
cells and HIV proviral DNA within the stromal-vascular-
fraction of virally-suppressed ART-treated patients [12]. 
In addition, we showed by in  vitro co-culture experi-
ments that primary human adipocytes enhance HIV 
replication in CD4 T cells [12]. As adipocytes are ubiq-
uitous endocrine cells that extensively regulate immunity 
and disease, these findings warrant further investigation 
into the role of adipose tissue in HIV replication and 
persistence.
SIV-infected rhesus macaques remain the best animal 
model for HIV infection and viral pathogenesis. In the 
present study, samples of adipose tissue were acquired 
from rhesus macaques at necropsy, which were infected 
with SHIV-SF162p3 for ~4 weeks (N = 8), or SIVmac251 
for ~38  weeks (N =  8), and not treated with antiretro-
viral drugs. We hypothesized that memory CD4 T cells 
in adipose tissue harbors infectious virus, and that these 
untreated infected monkeys would develop metabolic 
complications similar to HIV-infected humans. Although 
the original purpose of these infected monkeys did not 
include the study of adipose tissue, examination of their 
fat tissue demonstrated that infiltration of adipose tissue 
by CD4 T cells infected with infectious virus is a regu-
lar event during SIV infection. Long-term infection of 
monkeys also resulted in some metabolic abnormalities 
resembling those of HIV patients. The present findings 
highlight the prevalence and stability of the viral reser-
voir in adipose tissue, and provide novel evidence for 
viral-induced metabolic dysfunction.
Results
Establishment of reservoirs of memory CD4 T cells and SIV 
throughout adipose tissue during primary infection
Viral eradication is challenged by the rapidity with which 
SIV spreads throughout lymphoid tissues (within 7 days), 
and stable SIV reservoirs established (within 3 days) fol-
lowing infection of rhesus macaques [14, 15]. Adipose 
tissue inflammation and dysfunction typically involves 
the accumulation and regulatory activities of numerous 
innate and adaptive immune cells, particularly proinflam-
matory memory T cells, macrophages, and NKT cells. 
Thus, it is plausible that primary infection also includes 
viral dissemination and establishment of reservoirs in 
adipose tissue as adipocytes are intricately associated 
with most lymphoid tissues.
To examine the leukocyte and proviral distribution 
in adipose tissue during primary infection, adipose tis-
sue samples of acutely infected (SHIV-SF162p3) rhesus 
macaques were first studied. Figure  1a shows plasma 
viral loads after intra-rectal infection of nine monkeys, 
in which infection was unsuccessful for one monkey. 
Monkeys were necropsied ~4  weeks post-infection, 
and ~5–15  g of adipose tissue samples harvested from 
abdominal subcutaneous and visceral regions. AT-SVF 
cells were isolated from adipose tissue as described in 
“Methods” section, and visceral AT-SVF cells exam-
ined for activated memory T cells (CD3, CD4, CD8, 
CD95, CD25, and CD69), NKT cells (CD3, CD16, CD27, 
CD56, GrzA, and GrzB), B cells (CD19 and CD80), and 
macrophages (CD14 and HLA.DR) by flow cytometry 
(Additional file  1 shows the general method of AT-SVF 
isolation and gating schemes for flow cytometry analy-
ses). As mentioned in “Methods” section, over the course 
of the present study, adipose tissue samples were also 
obtained from various uninfected rhesus macaques that 
were healthy or experiencing health complications such 
as chronic enterocolitis, and were studied for comparison 
to SHIV-infected monkeys.
From total AT-SVF cells, CD3+ T cells accounted for 
~9.8 % for uninfected healthy monkeys, ~6.1 % for SHIV-
infected monkeys, and ~15.3 % for uninfected monkeys 
with chronic enterocolitis (Fig. 1b). Additionally, whereas 
CD8 and CD4 T cell levels were similar in AT-SVF of 
uninfected healthy monkeys (ratio of 1.38, p  =  0.18), 
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Fig. 1 Leukocyte and proviral distribution in the adipose tissue stromal-vascular-fraction (AT-SVF) of acutely infected monkeys. Visceral and sub-
cutaneous adipose tissue samples were harvested from rhesus macaques at necropsy. AT-SVF cells were isolated as described in “Methods” section 
and examined for leukocyte content (T cells, NKT cells, and macrophages) by flow cytometry, and SHIV DNA detection (Gag and Env) by nested 
PCR. a Plasma viral loads of SHIV-SF162p3-infected rhesus macaques (infection was successful for eight out of nine monkeys). b, c Mean ± SEM 
percentages of AT-SVF CD3+, or CD4 (CD3+CD4+) and CD8 (CD3+CD4−) T cells of uninfected healthy and SHIV-infected monkeys (*p < 0.05). For 
additional comparisons, AT-SVF T cells of uninfected rhesus macaques with chronic enterocolitis were also examined. d–f  Mean ± SEM percent-
ages of AT-SVF T cell memory (CD95) and activation (CD25 and CD69), NKT cell (CD16, CD27, CD56, GrzA, and GrzB), and macrophage (CD14 and 
HLA.DR) markers of uninfected healthy or SHIV-infected monkeys (*p < 0.05). g Nested PCR detection (2nd round gel bands) of SHIV-SF162p3 Gag 
and Env genes in DNA extracted from subcutaneous and visceral AT-SVF cells (~5 × 104–2 × 105 cell equivalents of DNA) of infected monkeys. DNA 
from PBMC, mesenteric lymph nodes, and intestinal tissue were also examined for comparison. PCR replicates of 6–9 were tested for AT-SVF cells, 
and replicates of three were tested for PBMC, MLN, and intestinal tissues
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the ratio of AT-SVF CD8 to CD4 T cells increased dur-
ing infection and disease (1.51 during SHIV infection, 
and 1.59 during chronic enterocolitis, p < 0.05) (Fig. 1c). 
For both uninfected healthy and SHIV-infected mon-
keys, nearly all of the AT-SVF CD4 and CD8 T cells 
were memory T cells (>94  % CD95+), which expressed 
tissue-resident and activation markers (62–84 % CD69+ 
and 3–13  % CD25+) (Fig.  1d). However, CD4 T cells 
expressed more CD25 (12–13  %) compared to CD8 T 
cells (3–4  %, p  <  0.0001), possibly indicative of Treg 
subsets. AT-SVF cells of uninfected healthy and SHIV-
infected monkeys were also comprised of similar levels of 
NKT cells (Fig. 1e), which were 3–8 % CD16+, 82–88 % 
CD27+, and 7–9 % CD56+ (gated on CD3+ cells), and 
27–30 % GrzA+ and 49–61 % GrzB+ (gated on CD3+/
CD56+ cells). Lastly, CD3-/CD14+/HLA.DR+ mac-
rophages represented a small proportion (<1–2  %) of 
total AT-SVF cells of uninfected healthy and SHIV-
infected monkeys (Fig.  1f ), and CD3-/CD19+/CD80+ 
B cells were not present in AT-SVF cells (<0.8  %, data 
not shown). Thus, primary SIV infection is associated 
with homing of the major reservoir cell, memory CD4 T 
cells, into adipose tissue, which is further associated with 
minor changes of T cell and macrophage distributions.
To examine the SHIV-SF162p3 proviral content in 
AT-SVF cells of acutely infected monkeys, a nested PCR 
assay was utilized since AT-SVF cell numbers were lim-
ited and CD4 T cells comprised a small proportion (usu-
ally less than ~5 %) of total AT-SVF cells. Approximately 
5 × 104–2 × 105 subcutaneous and visceral AT-SVF cell 
equivalents of DNA were used for each nested PCR reac-
tion (6–9 replicates for each sample). For comparison, 
DNA extracted from other tissues including PBMC, 
mesenteric lymph nodes, and intestinal tissues were also 
examined (replicates of three for each sample). SHIV 
DNA (Gag and Env) was readily detectable in AT-SVF 
samples of all eight infected monkeys (but absent in tis-
sues of the failed infection monkey), with more consistent 
detection in visceral AT-SVF samples compared to sub-
cutaneous AT-SVF (Fig. 1g). Additionally, the 2nd round 
PCR bands of AT-SVF samples were gel-purified and 
sequenced, which showed that Gag and Env sequences 
were virtually identical amongst all monkeys (Additional 
file  2), consistent with previous reports demonstrating 
high sequence homology and minimal viral evolution in 
tissues during early infection periods of rhesus macaques 
[16, 17]. These data show that memory CD4 T cells and 
SIV reservoirs are widely distributed throughout adipose 
tissue of rhesus macaques during primary infection.
Infectious SIV harbored by adipose tissue CD4 T cells
Despite the efficacy of antiretroviral therapy to sup-
press viral replication in HIV patients, persistence of 
latently-infected CD4 T cells that harbor dormant, but 
replication-competent, provirus remains a major obsta-
cle to eradication. These infected cells are unaffected by 
ART drugs and undetectable by antiviral CD8 T cells, 
and viral replication typically resumes within a month if 
therapy is discontinued. Whereas tissues such as lymph 
nodes containing CD4 T cells are important sources of 
rebound viremia, the contribution of other tissues such 
as the GALT is less clear [3, 18]. However, the presence of 
infectious virus in adipose tissue depots could also con-
tribute to systemic viremia.
To assess the infectiousness of SIV-infected CD4 T cells 
in adipose tissue, we conducted viral outgrowth assays 
on CD4 T cells purified from the AT-SVF of chronically 
SIVmac251-infected monkeys (infected for ~38  weeks, 
Fig.  2a shows plasma viral loads). CD4 T cells puri-
fied from peripheral blood or AT-SVF cells were serially 
diluted (twofold) six times and activated with PHA+IL-2 
for 2  days, followed by addition of M8166 cells for 
propagation of induced SIV (measured by extracellular 
p27). For five infected monkeys (RM’s 10–111, 10–138, 
10–189, 11–150, and 4–203), viral induction from 
peripheral blood CD4 T cells was examined in parallel to 
AT-SVF CD4 T cells, and for two infected monkeys (RM’s 
10–68 and 10–75), peripheral blood was unavailable and 
viral induction from only AT-SVF CD4 T cells was exam-
ined. For simplicity, Fig. 2b shows viral replication levels 
by the lowest input cell number in which extracellular 
p27 was detectable within 2 weeks post-induction (viral 
replication levels for all dilutions are shown in Addi-
tional file 3). In all seven monkeys examined, infectious 
SIV was inducible from AT-SVF CD4 T cells. Based on 
five monkeys, infectiousness appeared to be mostly com-
parable between peripheral blood and AT-SVF CD4 T 
cells by 3–4  weeks of culture, despite the starting input 
number of AT-SVF CD4 T cells (~1.4 × 103–1.3 × 104) 
being substantially less than peripheral blood CD4 T cells 
(~2.2 × 104–8.6 × 104) as shown in Fig. 2b.
We additionally assessed if infectious virions may be 
sequestered or trapped by mature adipocytes in the adi-
pocyte fraction of isolated adipose tissue samples, as it 
has been suggested that HIV may non-productively infect 
adipocytes [19]. From three infected monkeys, ~6 × 106 
M8166 cells were incubated with rotation at 37  °C in 
5–8 ml of visceral floater fraction suspension from each 
monkey for 8 h, followed by centrifugation, washing, and 
removal of dead M8166 cells by density-gradient centrif-
ugation. 3 × 106 M8166 cells were then cultured for up 
to 3 weeks and extracellular p27 measured, in which p27 
was not detected (data not shown), indicating a lack of 
infectious virion sequestration or trapping by adipocytes.
To further assess the function of adipose tissue CD8 T 
cells, viral outgrowth assays were attempted using total 
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Fig. 2 Infectiousness of SIV in peripheral blood and AT-SVF CD4 T cells of chronically infected rhesus macaques. a Plasma viral loads of chronically 
SIVmac251-infected monkeys. b Viral outgrowth of SIV from peripheral blood (PB) and adipose tissue (AT-SVF) CD4 T cells. PBMC was isolated from 
peripheral blood and AT-SVF cells isolated from adipose tissue of infected monkeys at necropsy. CD4 T cells were then purified from PBMC or AT-SVF 
cells, and activated with PHA + IL-2 and co-cultured with M8166 cells for 3–4 weeks in viral outgrowth assays as described in “Methods” section. 
Graphs show extracellular p27 levels from PBMC- or AT-SVF-derived CD4 T cells for five infected monkeys (numbers in parentheses indicate the 
input cell number at the start of the assay). For two infected monkeys (RM 10–68 and 10–75, bottom two plots), peripheral blood was unavailable, 
and an exact AT-SVF CD4 T cell count undetermined (but estimated at ~5 × 103–2 × 104 cells)
Page 6 of 14Couturier et al. Retrovirology  (2016) 13:30 
AT-SVF cells (without CD8 depletion) of three SHIV-
infected monkeys. Approximately 8.8  ×  105–1.3  ×  106 
starting input total AT-SVF cells were activated with 
PHA+IL-2, then co-cultured with M8166 cells for up 
to 3 weeks. However, SHIV induction was not observed 
(Fig. 3a), possibly due to the viral suppressive function of 
CD8 T cells as the majority of AT-SVF CD3+T cells were 
CD8+(AT-SVF CD8:CD4 ratios of 1.6–2.8). Addition-
ally, the peripheral blood and visceral AT-SVF CD8 and 
CD4 T cells of 4–5 SIV-infected monkeys were examined 
for proinflammatory cytokine functionality using flow 
cytometry ICS assays (Fig.  3b). Cytokine phenotypes of 
AT-SVF T cells were ~61 % TNFα+, ~27 % IL-2+, ~27 % 
IFNγ+, and ~3 % IL-17A+ for CD8 T cells, and ~33 % 
TNFα+, ~29 % IL-2+, ~20 % IFNγ+, and ~9 % IL-17A+ 
for CD4 T cells, which were similar to peripheral blood T 
cell cytokine profiles, suggesting that adipose tissue CD8 
T cells are highly functional. Thus, CD4 T cells in adipose 
tissue of SIV-infected rhesus macaques are infected with 
replication-competent and infectious virus, but such viral 
inducibility does not occur in the presence of adipose tis-
sue CD8 T cells.
Induction of metabolic perturbations by SIV infection 
in the absence of antiretroviral drugs
Metabolic dysfunction (such as dyslipidemias, hyper-
lipolysis, and decreased leptin and adiponectin produc-
tion) and adipocyte abnormalities (such as differentiation 
block due to blunted expression of key adipogenic tran-
scription factors) are prevalent during HIV infection. 
Whereas some of these defects have been attributed to 
the adverse effects of ART drugs, similar complications 
also occur in untreated or ART-naïve HIV patients. Addi-
tionally, viral proteins such as Vpr, Nef, and Tat impair 
adipocyte functions directly [20–24].
To determine if SIV infection induces adipose meta-
bolic defects in monkeys, we examined visceral adipocyte 
mRNA expression of C/EBPα, C/EBPβ, PPARγ2, leptin, 
adiponectin, and GLUT4, as well as serum total choles-
terol, lipids (triglycerides and free fatty acids), leptin, and 
adiponectin. As adipocytes extensively interact with T 
cells, we also examined adipocyte expression of factors 
that regulate T cell stimulation, survival, and migration 
(IL-2, IL-7, IL-15/IL-15Rα, IL-6, TNFα, CCL2, CCL5, 
CCL19, and CCL21). For adipocyte mRNA analyses, 
visceral adipose tissue was acquired from three unin-
fected healthy monkeys for comparison to three acutely 
infected and five chronically infected monkeys. Com-
pared to uninfected monkeys, differential expression 
of PPARγ2, C/EBPα, C/EBPβ, leptin, and GLUT4 was 
observed by adipocytes of infected monkeys (Fig.  4a). 
Relative to uninfected monkeys, PPARγ2 expression 
was increased 30.2-fold for acutely infected and 9.3-fold 
for chronically infected monkeys, whereas C/EBPα was 
decreased 2.9-fold for acutely infected and 2.5-fold for 
chronically infected monkeys, C/EBPβ was decreased 
4.3-fold for chronically infected monkeys, leptin was 
decreased 4.5-fold for acutely infected and 3.1-fold for 
chronically infected monkeys, and GLUT4 was decreased 
4.1-fold for acutely infected and 2.6-fold for chronically 
infected monkeys (p < 0.05). Adiponectin expression by 
adipocytes was similar between uninfected and infected 
monkeys. In conjunction with dysregulated expression of 
adipogenic factors, adipocytes of uninfected and infected 
monkeys also expressed important immune-regulatory 
factors (Fig. 4b). Adipocyte expression of IL-2, IL-7, and 
CCL19 was increased 1.6 to 3-fold in infected monkeys 
compared to uninfected monkeys (p  <  0.05), whereas 
expression of other cytokines and chemokines were simi-
lar between uninfected and infected monkeys, suggesting 
that adipocytes express factors that may contribute to the 
homing and survival of infected CD4 T cells in adipose 
tissue.
Consistent with the dysregulated expression of adipo-
cyte factors, abnormal serum levels of important meta-
bolic factors (total cholesterol, triglycerides, free fatty 
acids, leptin, and adiponectin) were observed in infected 
monkeys. When grouped by gender (eight acutely 
infected females, and four each chronically infected males 
and females) (since gender differences are well-known to 
influence metabolic parameters), and compared between 
baseline and necropsy time points, more changes of 
serum metabolites were observed in chronically infected 
monkeys. Bodyweights of acutely and chronically 
infected female monkeys were unchanged, but modestly 
increased for chronically infected males (Fig. 4c). Serum 
leptin levels were unchanged during acute infection, but 
modestly increased during chronic infection (Fig.  4d), 
whereas serum adiponectin levels were unchanged dur-
ing acute and chronic infection (Fig.  4e). Serum total 
cholesterol was unchanged during acute infection, but 
decreased for chronically infected males (Fig. 4f ). Serum 
triglycerides and free fatty acids were unchanged dur-
ing acute infection, whereas triglycerides were increased 
and free fatty acids decreased for chronically infected 
females (Fig. 4g, h). Lastly, these alterations of adipocyte 
and serum metabolism by chronically infected monkeys 
were observed in conjunction with high systemic viral 
loads (Fig.  2a), increased peripheral blood CD8 T cells, 
and increased serum inflammatory cytokines (Additional 
file 4), although changes in other tissues affected by HIV 
infection likely impact metabolic homeostasis as well. 
These data suggest that adipose tissue and systemic met-
abolic homeostasis of rhesus macaques are disrupted by 
SIV infection, which resemble metabolic complications 
of HIV patients.
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Discussion
A more complete understanding of cellular and anatomic 
compartments for HIV is important to permit targeted 
efforts to eradicate latent HIV infection. The present 
study demonstrates that adipose tissue of SIV-infected 
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Fig. 3 Multi-functionality of CD8 T cells in adipose tissue of infected rhesus macaques. a Lack of viral outgrowth from total AT-SVF cells (without 
CD8 T cell depletion) of three acutely SHIV-SF162p3-infected monkeys. Shown are input numbers of total AT-SVF cells at the start of the assay, and 
the ratio of AT-SVF CD8 to CD4 T cells. b, c Proinflammatory cytokine functionality of peripheral blood and AT-SVF T cells of chronically infected 
monkeys. Isolated PBMC or AT-SVF cells of SIVmac251-infected monkeys were untreated (UT) or stimulated with PMA/IO (in the presence of brefel-
din) for 5 h. Cells were then stained for CD3, CD8, TNFa, IL-2, IFNγ, and IL-17A and analyzed by flow cytometry. Shown are representative cytokine 
dotplots gated on peripheral blood or AT-SVF CD3+/CD8+ or CD3+/CD8− T cells after PMA/IO activation, and mean ± SEM cytokine expression 
(N = 4–5)
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Fig. 4 Alterations of adipocyte homeostasis and systemic metabolism during SIV infection of rhesus macaques. a, b mRNA expression of major adi-
pogenic and immunological factors by visceral adipocytes of uninfected healthy (N = 3), acutely infected (N = 3) and chronically infected (N = 5) 
monkeys at necropsy. Adipose tissue samples were digested with collagenase, then washed and centrifuged as described in “Methods” section 
to harvest mature adipocytes (floater fraction). mRNA was extracted from adipocytes and gene expression measured by real-time PCR (a indi-
cates p < 0.05 compared to uninfected monkeys, and b indicates p < 0.05 comparing chronic versus acute infection monkeys). c–h Mean ± SEM 
bodyweights and serum total cholesterol, triglycerides, free fatty acids, leptin, and adiponectin of acutely infected (eight females) and chronically 
infected (four females and four males) monkeys at baseline (prior to infection) and at necropsy
Page 9 of 14Couturier et al. Retrovirology  (2016) 13:30 
cells harboring infectious virus. In light of the extensive 
characterization of adipose tissue-immune system inter-
actions in recent years, it is significant that this study 
demonstrated an abundance of infectious virus in adi-
pose tissue. Adipocytes express numerous chemokines 
that recruit memory CD4 T cells and monocytes into 
adipose tissue, where T cells and macrophages differen-
tiate into proinflammatory subsets during disease and 
inflammation. Additionally, adipose tissue macrophages, 
stromal-vascular-fraction cells, and mature adipocytes 
activate CD4 T cells via soluble factors and direct con-
tact mechanisms, and furthermore promote T cell sur-
vival [25–27]. HIV replication by adipose tissue CD4 
T cells and macrophages may also be regulated by TLR 
stimulation, as breaches of intestinal epithelia result in 
infiltration of microbial products into visceral fat [28]. 
Furthermore, microbial pathogens such as M. tuberculo-
sis can establish reservoirs in adipocytes [29], which may 
influence the pathogenesis of HIV co-infections in adi-
pose tissue. Future investigations should focus on better 
understanding the mechanisms of antiviral immunity and 
efficacy of antiretroviral therapies in adipose tissue.
The rhesus macaques in the present study were infected 
with two different strains of virus (SHIV-SF162p3 or SIV-
mac251) for different time periods (~4 or ~38  weeks), 
and represented a range of viral loads, immunological 
parameters (CD4/CD8 cell counts and systemic cytokine 
levels), ages (2-16yo), and gender. Despite this biologi-
cal range, notable was the ease and consistency in which 
memory CD4 T cells, SHIV provirus, and infectious SIV 
could be detected in the adipose tissue of all infected 
monkeys studied (Figs.  1, 2). This corroborates recent 
studies demonstrating HIV- or SIV-infected immune 
cells in both subcutaneous and visceral fat of infected 
humans and cynomolgus macaques examined [12, 13], 
further emphasizing the regularity of viral dissemina-
tion throughout adipose tissue. In these investigations, 
it has been essential to examine specifically the stro-
mal-vascular-fraction of adipose tissue (following colla-
genase digestion to separate these cells from the mature 
adipocyte fraction), as mature adipocytes comprise the 
majority of adipose tissue, and only less than 5–10 % of 
total AT-SVF cells were CD4 T cells or macrophages. As 
shown in Fig.  1, the accumulation of infected immune 
cells in adipose tissue during acute infection was accom-
panied by minor changes in T cell and macrophage distri-
bution, possibly due to the short time period of infection. 
Compared to uninfected healthy monkeys, the adipose 
tissue CD4:CD8 T cell ratio of infected monkeys was 
slightly increased (suggesting increased CD4 depletion 
or increased CD8 homing), whereas macrophages were 
decreased and NKT cells unchanged (although exami-
nation of additional M1/M2 macrophage markers, and 
NKT cell markers such as NKG2A may indicate more 
distinct changes of these subsets). These findings indi-
cate that adipose tissue, particularly visceral fat, become 
a reservoir for SIV early during infection, and remain an 
infectious viral reservoir during longer-term infections.
The infectiousness of adipose tissue CD4 T cell SIV was 
mostly comparable to peripheral blood virus (Fig. 2), and 
such replication-competence suggests that adipose tissue 
infected CD4 T cells may contribute to systemic viremia 
or viral rebound. SIV replication was inducible from adi-
pose tissue CD4 T cells of all seven chronically infected 
monkeys examined, and from as few as ~1 ×  104 input 
AT-SVF CD4 T cells from most monkeys. This finding is 
also consistent with the report by Damouche et al., which 
demonstrated higher replication-competence by adipose 
tissue CD4 T cells compared to peripheral blood CD4 
T cells in ART-treated HIV patients [13]. This may be 
because CD4 T cells in adipose tissue, as well as in other 
extravascular tissues, are predominantly memory CD4 
T cells and the most productive host for HIV, by con-
trast to peripheral blood which contains mostly resting 
memory CD4 T cells and more naïve T cells. However, 
in the presence of multi-functional proinflammatory 
CD8 T cells, which comprised the majority of CD3 T 
cells in adipose tissue, propagation of infectious virus 
was inhibited (Fig. 3). Additionally, NKT cell populations 
(CD3+/CD16+/CD27+/CD56+/GrzA+/GrzB+) were 
also observed in AT-SVF of infected monkeys (Fig.  1e), 
which may exert additional antiviral functions. The pro-
inflammatory cytokine phenotypes of AT-SVF T cells 
of infected monkeys are also consistent with a range of 
models of adipose tissue inflammation which collectively 
depict that adipose tissue of healthy and lean humans 
and mice contain predominantly anti-inflammatory 
Tregs and Th2 cells, but shifts toward proinflammatory 
Th1 and Th17 cells during obesity and other diseases [10, 
30–34]. Such changes in CD4 T cell differentiation may 
yield more susceptible targets for HIV, as Th1 and Th17 
cells are more productive hosts for HIV compared to 
Tregs or Th2 cells [35–37]. It is unclear how viral replica-
tion levels by CD4 T cells and macrophages in adipose 
tissue compare to other tissues, and how well antiviral 
immunity suppresses replication, but the large mass of 
adipose tissue in the body suggests that it may be a large 
infectious reservoir.
Adipose tissue dysfunction is common amongst HIV 
patients, manifested by a range of clinical effects from 
dyslipidemia to lipoatrophy and fat “redistribution” [38, 
39]. The etiology of these manifestations is multifactorial, 
including the adverse effects of ART drugs, direct effects 
of viral proteins such as Vpr and Nef, and indirect effects 
of inflammation secondary to immune activation within 
adipose depots [40, 41]. The present study of untreated 
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acutely and chronically infected monkeys suggests that 
more metabolic changes occur as infection progresses over 
time. Additionally, interactions amongst activated immune 
cells and adipocytes in adipose tissue may promote inflam-
mation that precedes the systemic metabolic changes. 
Whereas acutely infected monkeys mostly experienced 
metabolic stability, chronically infected monkeys experi-
enced reduction of serum total cholesterol and increased 
triglycerides (Fig.  4f–h). Serum leptin was also increased 
in chronically infected monkeys (Fig.  4d), which for the 
males is consistent with their modest weight gain (Fig. 4c). 
This weight change may also be related to the increased 
densities of adipocytes and SVF cells observed in chroni-
cally SIV-infected (15 months) cynomolgus macaques [13]. 
Leptin can also promote T cell survival [42], which could 
influence HIV persistence in adipose tissue. Quantification 
of gene expression of factors critical for adipocyte differ-
entiation and function (PPARγ2, C/EBPα, C/EBPβ, leptin, 
adiponectin, and GLUT4) indicated that SIV infection 
decreased the expression of most of these genes (Fig. 4a), 
which may increase the risk for fat redistribution, lipoat-
rophy, or insulin resistance. Although metabolic changes 
in chronically infected monkeys occurred in conjunction 
with increased plasma cytokines (Additional file 4), factors 
derived from other tissues affected by viral infection, par-
ticularly lymphoid tissues proximal to adipose tissue, likely 
contribute to adipocyte dysfunction as well.
Some of these metabolic changes parallel adipose met-
abolic defects demonstrated in other animal models in 
the absence of ART drugs. For example, mouse models 
have shown that circulating Vpr induces dyslipidemias, 
increases energy expenditure, and suppresses adipogenic 
gene expression and adipocyte growth in  vitro [20, 22]. 
Soluble Nef can also mediate dyslipidemias in SIV-
infected rhesus macaques (infection for 2 months follow-
ing 6 months of a proatherogenic diet of high cholesterol 
and saturated fats) by decreasing liver ABCA1 expression 
and impairing reverse cholesterol transport [21]. These 
findings are further supported by in  vitro studies dem-
onstrating more directly the negative effects of Vpr, Nef, 
and Tat on adipocyte functions [22, 23, 43, 44]. Thus, in 
the absence of antiretroviral treatments, the metabolic 
changes in the infected monkeys of the present study 
provides further evidence that viral infection within 
the stromal-vascular-fraction of adipose depots and the 
resultant immunological alterations can perturb metabo-
lism and adipose tissue homeostasis.
Immune-regulatory factors that promote T cell hom-
ing and HIV replication was also expressed by adipocytes 
(Fig. 4b). Expression of these factors has been previously 
demonstrated in human and murine adipocytes [45–
47], but not in adipocytes of non-human primates. The 
common gamma-chain cytokines IL-2, IL-7, and IL-15 
are major regulators of T cell survival and homeostatic 
stimulation, but in combination with proinflammatory 
cytokines such as IL-6 and TNFα, and with other adi-
pocyte-secreted factors, can upregulate T cell activation 
and HIV replication [12, 48, 49]. Although these factors 
are generally upregulated in adipose tissue during infec-
tions and disease, substantial increases of immune cells 
were not observed in adipose tissue of acutely infected 
monkeys compared to uninfected monkeys as shown in 
Fig. 1, possibly due to the short time period of infection 
or the requirement for additional chemotactic signals 
from other stromal-vascular-fraction cells. Consistent 
with previous reports showing relatively high expression 
of CCL19 compared to other chemokines in human and 
murine adipocytes [50], we observed higher expression 
of CCL19 by adipocytes of infected monkeys compared 
to uninfected monkeys. During HIV infection, CCL19 
and CCL21 enhance steps of viral post-integration 
latency in CD4 T cells [51], which in combination with 
other stimulatory agents in adipose tissue, may facilitate 
the complete replication cycle of HIV. Thus, adipocyte 
immunokines may contribute to the homing and survival 
of infected CD4 T cells and macrophages in adipose tis-
sue, thus “seeding” the viral reservoir in this organ.
It is possible that the antiviral efficacy of ART drugs 
may be compromised in adipose tissue, since some of 
these drugs are lipophilic and can be sequestered within 
the relatively larger-sized adipocytes [52, 53]. Such 
sequestration might prevent the drugs from penetrating 
the stromal-vascular compartment harboring infected 
immune cells. In virally-suppressed ART-treated HIV 
patients, low-level viral replication in lymphoid tissue 
sanctuary sites, in association with inadequate penetra-
tion by ART drugs, has recently been reported as an 
important mechanism of viral persistence [4, 5]. Such 
sanctuary sites may exist in other tissues, and ongoing 
studies are investigating the penetration and efficacy of 
ART drugs in adipose tissue.
Conclusions
A better understanding of HIV reservoirs and anatomic 
sanctuaries is essential for treatment and eradication 
efforts. SIV-infected rhesus macaques represent the best 
animal model for HIV pathogenesis, and in the present 
study, fat tissues of infected monkeys are demonstrated 
to contain abundant memory CD4 T cells, highly infec-
tious virus, and proinflammatory immune cells. SIV 
infection furthermore induced metabolic complications 
in the absence of antiretroviral drugs, some of which 
resembled metabolic conditions of HIV patients. Thus, 
this major endocrine organ represents an expansive loca-
tion for SIV and HIV reservoirs that gradually becomes 
dysfunctional during viral infection.
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Methods
Animals and infections
All animal experiments were approved by the Institu-
tional Animal Care and Use Committee at the University 
of Texas MD Anderson Cancer Center and were carried 
out according to the provisions of the Animal Welfare 
Act, PHS Animal Welfare Policy, and the principles of 
the NIH Guide for the Care and Use of Laboratory Ani-
mals, and the policies and procedures of the University 
of Texas MD Anderson Cancer Center. Rhesus macaques 
(Macaca mulatta) of Indian origin were maintained in 
the specific pathogen-free breeding colony at the Michael 
Keeling Center for Comparative Medicine and Research 
of The University of Texas MD Anderson Cancer Center 
(Bastrop, Texas). The chamber size for the animals 
was 44′W ×  88′H ×  160′D. Monkeys were given water 
ad  libitum, and fed a commercial monkey diet (Har-
lan). Additional enrichment was provided in the form of 
manipulanda, visual stimulation or auditory stimulation, 
and combinations thereof. Animals were monitored daily, 
including weekends and holidays. Anesthetics/analgesics 
were used to minimize any discomfort, distress, pain, and 
injury the animal might experience. Animals were eutha-
nized with ketamine (11 mg/kg), followed by Beuthanasia 
(1 ml/10 lbs). If any animal was moribund, unresponsive 
to treatment, could not eat or drink, was severely sick, or 
had symptoms of SAIDS, it was euthanized as per guide-
lines. Animals were anesthetized during procedures to 
minimize discomfort.
For infections, monkeys were fasted for a minimum 
of 24  h prior to exposure. Monkeys were first anesthe-
tized with 10 mg/kg of body weight ketamine intramus-
cularly and 0.5  mg/kg xylazine, then placed in a sternal 
position with the pelvis propped at 45°. Monkeys were 
infected by intra-rectal inoculation of 1000 TCID50 clonal 
stocks of SHIV-SF162p3 or SIVmac251 (NIH AIDS Rea-
gent Program). The infected monkey was then returned 
to its cage and kept tilted at 45° until full recovery from 
anesthesia. RNA plasma viral loads were measured as 
previously described [54]. The SHIV-SF162p3-infected 
monkeys were necropsied ~4  weeks post-infection, and 
SIVmac251-infected monkeys necropsied ~38  weeks 
post-infection, and are referred to as acutely or chroni-
cally infected monkeys, respectively, throughout the 
manuscript.
During the course of the study, adipose tissue sam-
ples were also acquired from rhesus macaques that were 
uninfected and mostly healthy, or uninfected but afflicted 
with chronic enterocolitis. These samples were utilized 
for comparisons to the infected monkeys (i.e. adipose tis-
sue immune cell distribution or adipocyte gene expres-
sion studies) as indicated in the Results section. The 
demographic details of all the rhesus macaques used in 
the study are shown in Additional file 5.
Isolation of stromal‑vascular‑fraction (AT‑SVF) cells 
from adipose tissue, and PBMC isolation from peripheral 
blood
During necropsy of monkeys, adipose tissue samples 
(~5–15 g) were harvested from abdominal subcutaneous 
and visceral regions and immediately processed for AT-
SVF isolation. For AT-SVF isolation, ~1–3  g of adipose 
tissue at a time was minced with scissors, then digested 
with 1  mg/ml collagenase type II (Sigma) in 6  ml PBS 
in 15  ml conical tubes for 30–60  min (with rotation at 
37 °C). The digest was then centrifuged to pellet the AT-
SVF cells, whereas mature adipocytes (floater fraction) 
remained suspended due to lipid droplet buoyancy. The 
adipocytes were harvested and stored at  −80 °C for real-
time PCR analyses. The AT-SVF cells were then washed 
with PBS/2  % FBS, filtered through 70  µm mesh, and 
maintained in complete RPMI-1640 medium (10 % FBS, 
2  mM l-glutamine, 0.1  mM MEM nonessential amino 
acids, 2  mM sodium pyruvate, 25  mM HEPES, and 1X 
antibiotic–antimycotic) at 37 °C/5 % CO2 prior to experi-
ments. AT-SVF cell yields were usually ~2 × 105–8 × 105 
cells per gram of adipose tissue.
PBMC were isolated from EDTA-anticoagulated whole 
blood by overlay onto Ficoll-Paque PLUS (GE Health-
care) and density-gradient centrifugation. PBMC were 
then washed and maintained in complete RPMI medium 
prior to experiments.
Flow cytometry
Antibodies for flow cytometry analyses were obtained 
from Biolegend, BD Biosciences, or eBioscience. For 
examination of PBMC and AT-SVF leukocytes, cells were 
washed with PBS/2  % FBS and stained with the follow-
ing mabs: CD3-Pacblue, CD4-PerCPCy5.5, CD8-FITC, 
CD95-PE, CD25-PECy7, and CD69-APC for T cells; 
CD3-Pacblue, CD16-AF700, CD56-PE, GrzB-AF647, and 
either GrzA-PerCPCy5.5 or CD27-PerCPCy5.5 for NKT 
cells (intracellular GrzA and GrzB were stained using BD 
Biosciences Cytofix/Cytoperm solutions); CD19-PE and 
CD80-FITC for B cells; and CD14-Pacblue, CD16-PE, 
and HLA.DR-APCCy7 for macrophages. Isotype controls 
were used to assess non-specific binding, and compen-
sation settings determined with single-color and fluo-
rescence-minus-one (FMO) controls. Data was acquired 
with a Gallios Flow Cytometer and analyzed with Kaluza 
software (Beckman-Coulter).
For intracellular cytokine secretion (ICS) assays, 
PBMC or AT-SVF cells were stimulated with PMA/IO 
in the presence of GolgiPlug (BD Biosciences Leukocyte 
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Activation Cocktail) for 5  h. Cells were washed with 
PBS/2  % FBS and stained with viability dye and surface 
mabs (CD3-PerCPCy5.5, CD8-FITC or CD8-APCCy7) 
for 30  min, followed by fixation/permeabilization with 
Cytofix/Cytoperm solution (BD Biosciences) for 30 min. 
Cells were then washed with Perm/Wash buffer and 
incubated with intracellular mabs (TNFα-PECy7, IL-
2-AF700, IFNγ-PE, or IL-17A-PE) for 30 min. Cells were 
washed and analyzed by flow cytometry.
Nested PCR and DNA sequencing
DNA extraction was conducted using QIAamp DNA 
Micro Kit (QIAGEN). Nested PCR was performed for 
detection of SHIV-SF162p3 DNA (SIVmac239 Gag and 
HIV-1 Env) in cells of acutely infected monkeys, and 
primers are listed in Additional file 6. 1st round reactions 
included 40 μl PCR SuperMix (Life Technologies), 200–
300 nM primers, 0.1 μg DNA, and 10 μl water; PCR con-
ditions were one cycle at 94 °C (2 min), then 35–40 cycles 
at 94  °C (30 s), 55  °C (30 s), and 72  °C (55 s), then final 
extension at 72  °C (10  min). 2nd round reactions were 
40  μl PCR SuperMix, 200–300  nM primers, 3  μ1 of 1st 
round product, and 10 μl water, and PCR conditions were 
one cycle at 94  °C (2  min), then 35–40 cycles at 94  °C 
(30 s), 55 °C (30 s), and 72 °C (30 s), then final extension 
at 72  °C (10  min). 2nd round PCR products were then 
gel-purified and sequenced by the Baylor College of Med-
icine DNA Sequencing Core (using ABI 3130XL Genetic 
Analyzer and BigDye Terminator). Multiple sequence 
alignments were conducted with Clustal Omega.
CD4 T cell purification and viral outgrowth assays
CD4 T cells were purified from PBMC or AT-SVF cells 
of infected rhesus macaques using bead-based posi-
tive selection kits (Stemcell Technologies), and purity 
assessed by flow cytometry. Induction and propagation 
of SIV replication was conducted using a previously 
described viral outgrowth method with minor modifica-
tions [55]. Cells were serially diluted (twofold) six times 
and activated with 5  µg/ml PHA-L+50  ng/ml IL-2 in 
complete RPMI medium (3 ml) for 2 days. Medium was 
then replenished and PHA-L removed, followed by addi-
tion of 2  ×  105 M8166 cells (NIH AIDS Reagent Pro-
gram) for viral propagation. Cells were cultured for up 
to 3–4  weeks, in which medium was replenished every 
3–4 days and cultures split every 6–7 days. Extracellular 
p27 was measured by sandwich ELISA kits (XpressBio).
Serum analyte measurements
Serum of infected monkeys was collected by centrifu-
gation of anti-coagulated whole blood and storage at 
−80  °C. Serum cytokines were measured using the 
MILLIPLEX Non-Human Primate Immunology Mul-
tiplex Assay (EMD Millipore), and analyzed with a Bio-
Plex 200 System (Bio-Rad). Serum total cholesterol was 
measured by Infinity Cholesterol Liquid Stable Reagent 
(Thermo Scientific), serum triglycerides were measured 
using Triglycerides Reagent kit (Thermo Scientific), and 
serum free fatty acids were measured using NEFA-HR(2) 
kit (Wako Diagnostics). Serum leptin was measured 
using Non-Human Primate Leptin competitive ELISA 
kit (NeoScientific), and serum adiponectin (Acrp30) was 
measured using LEGEND MAX sandwich ELISA kit 
(Biolegend).
Real‑time PCR
Total RNA was extracted from the floater fraction adi-
pocytes of collagenase-digested adipose tissue samples 
using RNeasy Lipid Tissue Mini Kit (QIAGEN). RNA was 
reverse-transcribed to cDNA, and SYBR Green real-time 
PCR performed using the ABI 7300 System (Applied Bio-
systems). Primers (Additional file 7) were designed using 
Primer Express and synthesized by Sigma Genosys. Reac-
tion conditions were one cycle at 95 °C (10 min), followed 
by 40 cycles of 95 °C (30 s), 55 °C (60 s), and 72 °C (60 s), 
and ended with one cycle of 95 °C (60 s), 55 °C (30 s), and 
95 °C (30 s). GAPDH was used as the calibrator for nor-
malization of gene expression, and fold changes were cal-
culated using 2−ΔΔCT formula.
Statistics
Data were analyzed with GraphPad Prism or Microsoft 
Excel. Comparisons utilized two-tailed student’s t test 
(paired or unpaired as appropriate), and p values less 
than 0.05 were considered significant.
Additional files
Additional file 1. General method for isolation of stromal-vascular-
fraction (AT-SVF) cells from adipose tissue of rhesus macaques, and 
subsequent analyses. (A) 30-60 mins collagenase digestion of solid 
adipose tissue samples from rhesus macaques is followed by washing and 
centrifugation, allowing for separation of mature adipocytes (floater frac-
tion) from the stromal-vascular-fraction (AT-SVF) cells. AT-SVF cells were 
then analyzed by flow cytometry, nested PCR, and viral outgrowth assays, 
and floater fraction adipocytes analyzed for mRNA expression. (B) Sample 
flow cytometry gating schemes for examination of AT-SVF T cells, NKT 
cells, macrophages, and B cells.
Additional file 2. Sequence confirmation of nested PCR products, and 
lack of viral diversity in AT-SVF of acutely infected rhesus macaques. PCR 
products from SHIV Gag (A) and Env (B) 2nd round nested PCR reactions 
of subcutaneous and visceral AT-SVF DNA of eight infected monkeys 
(shown in Figure 2G) were gel-purified, sequenced, and aligned with 
Clustal-Omega software. Yellow-highlighted nucleotides indicate a 
nucleotide difference compared to other nucleotides in the alignment 
column (sequences include nucleotide positions A:1667 to G:2085 rela-
tive to SIVmac239 Gag, and G:7042 to C:7329 relative to HIV-1 HXB2 Env, 
indicated in red).
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